• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质激酶抑制剂复合物的分子动力学:有效的结构信息。

Molecular dynamics of protein kinase-inhibitor complexes: a valid structural information.

机构信息

Escuela de Ingeniería en Bioinformática, Centro de Bioinformática y Simulación Molecular, Universidad de Talca, 2 Norte 685, Casilla 721, Talca, Chile.

出版信息

Curr Pharm Des. 2012;18(20):2946-63. doi: 10.2174/138161212800672705.

DOI:10.2174/138161212800672705
PMID:22571663
Abstract

Protein kinases (PKs) are key components of protein phosphorylation based signaling networks in eukaryotic cells. They have been identified as being implicated in many diseases. High-resolution X-ray crystallographic data exist for many PKs and, in many cases, these structures are co-complexed with inhibitors. Although this valuable information confirms the precise structure of PKs and their complexes, it ignores the dynamic movements of the structures which are relevant to explain the affinities and selectivity of the ligands, to characterize the thermodynamics of the solvated complexes, and to derive predictive models. Atomistic molecular dynamics (MD) simulations present a convenient way to study PK-inhibitor complexes and have been increasingly used in recent years in structure-based drug design. MD is a very useful computational method and a great counterpart for experimentalists, which helps them to derive important additional molecular information. That enables them to follow and understand structure and dynamics of protein-ligand systems with extreme molecular detail on scales where motion of individual atoms can be tracked. MD can be used to sample dynamic molecular processes, and can be complemented with more advanced computational methods (e.g., free energy calculations, structure-activity relationship analysis). This review focuses on the most commonly applications to study PK-inhibitor complexes using MD simulations. Our aim is that researchers working in the design of PK inhibitors be aware of the benefits of this powerful tool in the design of potent and selective PK inhibitors.

摘要

蛋白激酶(PKs)是真核细胞中基于蛋白质磷酸化的信号转导网络的关键组成部分。它们已被确定与许多疾病有关。许多 PK 都有高分辨率的 X 射线晶体学数据,在许多情况下,这些结构与抑制剂共同复合。尽管这些有价值的信息证实了 PK 及其复合物的精确结构,但它忽略了结构的动态运动,这些运动对于解释配体的亲和力和选择性、描述溶剂化复合物的热力学以及得出预测模型是相关的。原子分子动力学(MD)模拟为研究 PK-抑制剂复合物提供了一种便捷的方法,近年来在基于结构的药物设计中得到了越来越多的应用。MD 是一种非常有用的计算方法,也是实验人员的绝佳搭档,它可以帮助他们得出重要的额外分子信息。这使他们能够以极端分子细节跟踪和理解蛋白质-配体系统的结构和动力学,在单个原子运动可以被追踪的尺度上。MD 可用于采样动态分子过程,并可与更先进的计算方法(例如自由能计算、结构-活性关系分析)相结合。本综述重点介绍了使用 MD 模拟研究 PK-抑制剂复合物的最常见应用。我们的目的是让从事 PK 抑制剂设计的研究人员意识到这种强大工具在设计有效和选择性 PK 抑制剂方面的优势。

相似文献

1
Molecular dynamics of protein kinase-inhibitor complexes: a valid structural information.蛋白质激酶抑制剂复合物的分子动力学:有效的结构信息。
Curr Pharm Des. 2012;18(20):2946-63. doi: 10.2174/138161212800672705.
2
Advanced molecular dynamics simulation methods for kinase drug discovery.用于激酶药物发现的先进分子动力学模拟方法。
Future Med Chem. 2016 Apr;8(5):545-66. doi: 10.4155/fmc.16.9. Epub 2016 Apr 7.
3
Uncovering Molecular Bases Underlying Bone Morphogenetic Protein Receptor Inhibitor Selectivity.揭示骨形态发生蛋白受体抑制剂选择性背后的分子基础。
PLoS One. 2015 Jul 2;10(7):e0132221. doi: 10.1371/journal.pone.0132221. eCollection 2015.
4
Using molecular simulation to explore the nanoscale dynamics of the plant kinome.利用分子模拟探索植物激酶组的纳米级动力学。
Biochem J. 2018 Mar 9;475(5):905-921. doi: 10.1042/BCJ20170299.
5
Theoretical study on the interaction of pyrrolopyrimidine derivatives as LIMK2 inhibitors: insight into structure-based inhibitor design.吡咯并嘧啶衍生物作为LIMK2抑制剂相互作用的理论研究:基于结构的抑制剂设计洞察
Mol Biosyst. 2013 Oct;9(10):2435-46. doi: 10.1039/c3mb70168a.
6
Predicting the open conformations of protein kinases using molecular dynamics simulations.利用分子动力学模拟预测蛋白激酶的开放构象。
Biopolymers. 2012 Jan;97(1):65-72. doi: 10.1002/bip.21704. Epub 2011 Aug 19.
7
Molecular simulation studies on the binding selectivity of 2-anilino-4-(thiazol-5-yl)-pyrimidines in complexes with CDK2 and CDK7.2-苯胺基-4-(噻唑-5-基)嘧啶与CDK2和CDK7复合物结合选择性的分子模拟研究
Mol Biosyst. 2016 Jan;12(1):145-61. doi: 10.1039/c5mb00630a.
8
Recent advances in designing substrate-competitive protein kinase inhibitors.设计底物竞争性蛋白激酶抑制剂的最新进展。
Curr Pharm Des. 2012;18(20):2875-82. doi: 10.2174/138161212800672697.
9
Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.通过基于药效团的设计、3D-QSAR 和针对阿尔茨海默病的分子动力学模拟来鉴定潜在的蛋白激酶 C 抑制剂。
J Biomol Struct Dyn. 2018 Nov;36(15):4029-4044. doi: 10.1080/07391102.2017.1406824. Epub 2017 Dec 13.
10
Investigation of the differences in activity between hydroxycycloalkyl N1 substituted pyrazole derivatives as inhibitors of B-Raf kinase by using docking, molecular dynamics, QM/MM, and fragment-based de novo design: study of binding mode of diastereomer compounds.利用对接、分子动力学、QM/MM 和基于片段的从头设计研究羟基环烷基 N1 取代吡唑衍生物作为 B-Raf 激酶抑制剂的活性差异:非对映异构体化合物结合模式研究。
J Chem Inf Model. 2011 Nov 28;51(11):2920-31. doi: 10.1021/ci200306w. Epub 2011 Oct 31.

引用本文的文献

1
Methods for Design of Kinase Inhibitors as Anticancer Drugs.激酶抑制剂作为抗癌药物的设计方法。
Front Chem. 2020 Jan 8;7:873. doi: 10.3389/fchem.2019.00873. eCollection 2019.
2
How peptide/MHC presence affects the dynamics of the LC13 T-cell receptor.肽/MHC 存在如何影响 LC13 T 细胞受体的动力学。
Sci Rep. 2019 Feb 25;9(1):2638. doi: 10.1038/s41598-019-38788-0.
3
Mycobacterium tuberculosis serine/threonine protein kinases: structural information for the design of their specific ATP-competitive inhibitors.结核分枝杆菌丝氨酸/苏氨酸蛋白激酶:设计其特异性 ATP 竞争抑制剂的结构信息。
J Comput Aided Mol Des. 2018 Dec;32(12):1315-1336. doi: 10.1007/s10822-018-0173-3. Epub 2018 Oct 26.
4
Computational Studies of Snake Venom Toxins.蛇毒毒素的计算研究。
Toxins (Basel). 2017 Dec 22;10(1):8. doi: 10.3390/toxins10010008.
5
Computational Methods Applied to Rational Drug Design.应用于合理药物设计的计算方法
Open Med Chem J. 2016 Apr 26;10:7-20. doi: 10.2174/1874104501610010007. eCollection 2016.
6
Is It Reliable to Use Common Molecular Docking Methods for Comparing the Binding Affinities of Enantiomer Pairs for Their Protein Target?使用常见分子对接方法比较对映体对与其蛋白质靶点的结合亲和力是否可靠?
Int J Mol Sci. 2016 Apr 20;17(4):525. doi: 10.3390/ijms17040525.
7
Overview of simulation studies on the enzymatic activity and conformational dynamics of the GTPase Ras.GTP酶Ras的酶活性和构象动力学模拟研究综述
Mol Simul. 2014;40(10-11):839-847. doi: 10.1080/08927022.2014.895000. Epub 2014 Mar 19.
8
Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies?靶向血液系统恶性肿瘤中的蛋白质-蛋白质相互作用:仍然是一项挑战还是未来治疗的巨大机遇?
Immunol Rev. 2015 Jan;263(1):279-301. doi: 10.1111/imr.12244.
9
Insights into the interactions between maleimide derivates and GSK3β combining molecular docking and QSAR.结合分子对接和定量构效关系深入了解马来酰亚胺衍生物与糖原合成酶激酶3β之间的相互作用。
PLoS One. 2014 Jul 10;9(7):e102212. doi: 10.1371/journal.pone.0102212. eCollection 2014.
10
Docking and quantitative structure-activity relationship of oxadiazole derivates as inhibitors of GSK3β.作为 GSK3β 抑制剂的恶二唑衍生物的对接和定量构效关系。
Mol Divers. 2014 Feb;18(1):149-59. doi: 10.1007/s11030-013-9483-5. Epub 2013 Oct 1.